BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Targeting histone trimethylation to treat Alzheimer’s

By Claire Quang, Staff Writer
January 30, 2021 1:06 AM UTC

DISEASE CATEGORY: Neurology

INDICATION: Alzheimer’s disease...

BCIQ Company Profiles

University at Buffalo

BCIQ Target Profiles

Myeloid-lymphoid or mixed-lineage leukemia protein (MLL1) (MLL) (HRX) (KMT2A)

Serum/glucocorticoid regulated kinase 1 (SGK1)

WD repeat domain 5 (WDR5)

BCIQ Company Profiles

University at Buffalo

BCIQ Target Profiles

Myeloid-lymphoid or mixed-lineage leukemia protein (MLL1) (MLL) (HRX) (KMT2A)

Serum/glucocorticoid regulated kinase 1 (SGK1)

WD repeat domain 5 (WDR5)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS